中文名稱:司韋單抗 | 英文名稱:Research Grade Sevirumab (DVV05101) |
CAS:138660-96-5 | 純度規(guī)格: PAGE:>95% |
產(chǎn)品類別: 藥物對照抗體 | |
抗體名: Research Grade Sevirumab (DVV05101) | 靶點(diǎn): Envelope glycoprotein H, gH, gH, UL75 |
宿主: Homo sapiens | 適應(yīng)物種: HHV-5 |
克隆性: Monoclonal | 藥物對照抗體: Research Grade Sevirumab (DVV05101) |
Catalog No.
DVV05101
Host species
Homo sapiens
Species reactivity
HHV-5
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Concentration
1 mg/ml
Purity
>95% by SDS-PAGE.
Clonality
Monoclonal
Isotype
IgG1, kappa
Applications
Research Grade Biosimilar
Target
Envelope glycoprotein H, gH, gH, UL75
Purification
Protein A or G purified from cell culture supernatant.
Endotoxin level
Please contact with the lab for this information.
Expression system
XtenCHO
Accession
P12824
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Alternative Names
EV2 7, MSL 109, SDZ MSL 109, CAS: 138660-96-5, Human HerpesVirus (HHV/HCMV)
Note
For research use only. Not suitable for clinical or therapeutic use.
成立日期 | 2021-04-08 (5年) | 注冊資本 | 500萬 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1000萬-5000萬 |
主營行業(yè) | 生物化工,技術(shù)服務(wù) | 經(jīng)營模式 | 試劑 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP4年
|
湖北魏氏化學(xué)試劑股份有限公司
|
2025-08-14 | |
¥598 |
VIP4年
|
湖北魏氏化學(xué)試劑股份有限公司
|
2025-08-14 | |
¥3800 |
VIP4年
|
湖北魏氏化學(xué)試劑股份有限公司
|
2025-08-06 |